About AVT
Browse Articles
Customer Services


Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg

Jintanat Ananworanich, Umaporn Siangphoe, Apicha Mahanontharit, Andrew Hill, Bernard Hirschel, Kiat Ruxrungtham

Corresponding author name: Jintanat Ananworanich
Corresponding author e-mail: jintanat.a@chula.ac.th

Citation: Antiviral Therapy 2004; 9:1035-1036


No abstract included.


Copyright © 2020 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.